Amneal launches PEMRYDI RTU, ready-to-use version of pemetrexed, oncology injectable medicine Read more
Allecra’s EXBLIFEP approval to treat cUTIs provides valuable new weapon to tackle ESBL mediated AMR: GlobalData Read more
Zydus gets USFDA nod for Dexamethasone Tablets USP, 0.5 mg, 0.75 mg, 1.5 mg, 4 mg and 6 mg and Dexamethasone Tablets USP, 2 mg Read more